Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Cited by papers we hold 4

• RNA modification: mechanisms and therapeutic targets · 2023
  No notice
• The Roles of 2-Hydroxyglutarate · 2021
  No notice
• IDH mutation in glioma: molecular mechanisms and potential therapeutic targets · 2020
  No notice
• The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.